Skip to content
drillr.ai
Sign up

02348.HK

Dawnrays Pharmaceutical (Holdings) Limited

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK

HKD 0.99
−1.50%
Ask drillr

  • Aug 28, 2026, 10:20 UTC

    Dongrui Pharmaceutical declared an interim dividend of HKD 0.015 per share for the six months ended June 2026, unchanged from the prior year.

    Source:

  • Aug 28, 2026, 10:20 UTC

    Dongrui Pharmaceutical announced its interim results for the six months ended June 2026, with revenue of RMB 546 million, down 13.4% year-on-year, and net profit of RMB 123 million, up 18% year-on-year.

    Source: